Table 3.
Standardized regression coefficients of characteristics of psychotherapy and pharmacotherapy studies
| Full model | Parsimonious model | ||||||
|---|---|---|---|---|---|---|---|
| Coef. | 95% CI | p | Coef. | 95% CI | p | ||
| Disorder | |||||||
| MDD | Ref. | ||||||
| Dysthymia | −0.01 | −0.46 to 0.43 | |||||
| Other mood disorder | 0.02 | −0.42 to 0.45 | |||||
| Panic disorder | −0.10 | 0.42 to 0.21 | |||||
| SAD | 0.12 | −0.28 to 0.53 | |||||
| OCD | 0.52 | 0.01 to 1.03 | <0.05 | 0.76 | 0.36 to 1.15 | <0.001 | |
| Other anxiety disorder | 0.32 | −0.30 to 0.95 | |||||
| Recruitment from clinical samples only | 0.05 | −0.17 to 0.26 | |||||
| Adults in general vs. specific target group | −0.41 | −0.70 to-0.13 | <0.01 | −0.27 | −0.50 to - 0.05 | <0.05 | |
| Psychotherapy | |||||||
| CBT | Ref. | ||||||
| ITP | −0.16 | −0.45 to 0.12 | |||||
| Counseling | −0.51 | −0.92 to −0.19 | <0.05 | −0.41 | −0.72 to −0.09 | <0.05 | |
| Other therapy | −0.03 | −0.39 to 0.33 | |||||
| Pharmacotherapy | |||||||
| SSRI | Ref. | ||||||
| TCA | 0.32 | 0.06 to 0.58 | <0.05 | 0.31 | 0.11 to 0.50 | <0.01 | |
| MAOI | 0.07 | −0.34 to 0.48 | |||||
| Other | −0.23 | −0.51 to 0.05 | |||||
| Individual psychotherapy format | 0.01 | −0.27 to 0.28 | |||||
| Number of psychotherapy sessions | 0.01 | −0.02 to 0.04 | |||||
| Quality of study | 0.00 | −0.07 to 0.08 | |||||
| Country | |||||||
| USA | Ref. | ||||||
| Europe | 0.26 | 0.03 to 0.49 | <0.05 | 0.18 | 0.00 to 0.36 | <0.05 | |
| Other | −0.00 | −0.31 to 0.31 | |||||
| Constant | 0.31 | −0.29 to 0.91 | 0.09 | −0.12 to 0.29 | |||
MDD – major depressive disorder, SAD – social anxiety disorder, OCD – obsessive-compulsive disorder, CBT – cognitive-behavioral therapy, ITP – interpersonal psychotherapy, SSRI – selective serotonin reuptake inhibitor, TCA – tricyclic antidepressant, MAOI – monoamine oxidase inhibitor